Valuation: CeriBell, Inc.

Market Cap 642M 564M 524M 481M 904M 61.79B 918M 6.22B 2.43B 30.38B 2.41B 2.36B 105B P/E 2026 *
-9.91x
P/E 2027 * -14.7x
Enterprise Value 628M 552M 513M 471M 885M 60.51B 899M 6.09B 2.38B 29.75B 2.36B 2.31B 103B EV / Sales 2026 *
5.51x
EV / Sales 2027 * 4.23x
Free-Float
87.21%
Yield 2026 *
-
Yield 2027 * -
1 day+3.87%
1 week-9.67%
Current month-13.06%
1 month-15.37%
3 months-20.16%
6 months-23.38%
Current year-22.89%
1 week 15.96
Extreme 15.96
18.57
1 month 15.96
Extreme 15.96
20.46
Current year 15.84
Extreme 15.84
24.33
1 year 10.85
Extreme 10.85
24.33
3 years 10.01
Extreme 10.01
32.75
5 years 10.01
Extreme 10.01
32.75
10 years 10.01
Extreme 10.01
32.75
Manager TitleAgeSince
Chief Executive Officer 46 2015-09-30
Director of Finance/CFO 44 2020-03-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 46 2014-08-28
Chairman 57 2014-08-28
Director/Board Member 64 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Sell

Founder

-89,000 0.2346%
6/30/26 Sell

Director

-2,207 0.0058%
6/26/26
TPG Group Holdings (SBS) Advisors, Inc.
SellCompany -202,368 0.5334%
Change 5-day change 1-year change 3-year change Capi.($)
+3.87%-9.67%+11.76% - 642M
+1.42%-1.52%-18.62%+5.39% 3.59B
-2.36%-13.76%+27.25% - 1.23B
0.00%+4.78%-6.07%-2.95% 148M
-1.04%-2.67%+58.43%+67.08% 120M
Average +0.38%-3.36%+14.55%+23.17% 1.15B
Weighted average by Cap. +0.79%-4.82%-3.41%+6.98%

Financials

2026 *2027 *
Net sales 114M 100M 93.11M 85.44M 161M 10.98B 163M 1.11B 432M 5.4B 428M 419M 18.66B 146M 128M 119M 109M 205M 14.05B 209M 1.41B 553M 6.91B 548M 536M 23.88B
Net income -65.38M -57.43M -53.4M -49.01M -92.08M -6.3B -93.5M -634M -248M -3.1B -245M -240M -10.7B -44.3M -38.91M -36.18M -33.2M -62.38M -4.27B -63.35M -430M -168M -2.1B -166M -163M -7.25B
Net Debt -13.26M -11.65M -10.83M -9.94M -18.67M -1.28B -18.96M -129M -50.24M -628M -49.77M -48.7M -2.17B -24.76M -21.75M -20.23M -18.56M -34.88M -2.38B -35.41M -240M -93.84M -1.17B -92.97M -90.96M -4.05B
Logo CeriBell, Inc.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its hardware is composed of disposable, flexible headbands and head caps (Wearables) and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals. EEG data captured by the recorder are interpreted by its proprietary AI-powered seizure detection algorithms, which monitor the patient’s EEG signal and support the clinician’s real-time assessment of seizure activity.
Employees
327
Date Price Change Volume
26-07-24 US$16.91 +3.87% 363,473
26-07-23 US$16.28 -3.21% 406,282
26-07-22 US$16.82 -5.98% 523,545
26-07-21 US$17.89 -2.93% 288,843
26-07-20 US$18.43 -1.55% 231,408
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
16.91USD
Average target price
26.86USD
Spread / Average Target
+58.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CBLL Stock